相关实验视频

Updated: Jun 11, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

高表达ARHGEF5预测急性髓性白血病的不良预后

Haitao Xu¹, Dangui Chen², Jia Lu²

¹Department of Hematology, Anqing Municipal Hospital, Anqing Medical Center Affiliated to Anhui Medical University, Anqing, 246003, Anhui, China. danielxu9@163.com.

Discover oncology

|September 27, 2024

概括

过度表达Rho关氨酸核酸交换因子5 (ARHGEF5) 与急性髓性白血病 (AML) 的预后不佳有关. 这一发现表明ARHGEF5可能是一个有价值的生物标志物,用于预测AML患者的结果.

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

急性髓性白血病 (AML) 是一种复杂的血液癌症,需要新的预后标志物.
罗瓜核酸交换因子5 (ARHGEF5) 与其他癌症有关,但其在AML中的作用尚不清楚.

研究的目的:

研究ARHGEF5在AML中的表达.
确定ARHGEF5表达和患者预后之间的相关性.
确定与AML中的ARHGEF5相关的分子通路.

主要方法:

利用癌症基因组图谱 (TCGA) 数据库用于AML患者数据.
在AML和正常样本中的ARHGEF5表达的比较使用Wilcoxon等级和值测试.
通过卡普兰-梅尔和考克斯回归分析 (CRA) 评估生存结果.
构建了一个结合年龄和细胞遗传风险的预后名录.

主要成果:

与正常对照组相比,ARHGEF5在AML患者中显著过度表达.
高ARHGEF5表达与不良预后相关,特别是在特定患者亚组 (年龄≤60岁,NPM1/FLT3突变,野生型RAS).
CRA证实ARHGEF5是预后不佳的独立预测因素.
确定了412个差异表达的基因和与ARHGEF5水平相关的相关途径.

结论:

过度表达ARHGEF5是急性髓性白血病不良结果的潜在生物标志物.
ARHGEF5可能在AML的发病和进展中发挥作用.
对ARHGEF5的进一步研究可能会为AML的新疗法策略提供信息.

关键词:

阿尔赫盖夫5 在线观看急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.预测预后预测预测在R包中,R包是R包.癌症基因组图集癌症基因组图集

更多相关视频

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...